On September 10, 2025, Roivant Sciences Ltd. held its Annual General Meeting where shareholders approved three proposals, including the re-election of directors and the appointment of Ernst & Young as auditors for 2026. Out of 682.5 million shares, 628.7 million were represented at the meeting.